ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Ranitidin-Mepha® 150/300/:Mepha Pharma AG
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
A02BA02 - RanitidineATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A02 - Drugs for Acid Related Disorders
 
A02B - Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
 
A02BA - H2-Receptor Antagonists

Ranitidine bismuth citrate is classified here, whereas other bismuth salts are classified in A02BX.

The DDDs are based on treatment of peptic ulcers.

A02BA02 - Ranitidine
DoseRoute of administrationNote
 P 
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home